“Other Income (Expense), Net The following table presents OI&E (in millions): Three Months Ended March 31, 2025 2026 Interest income $ 1,001 $ 1,381 Interest expense (34) (533) Foreign currency exchange gain (loss), net (106) 146 Gain (loss) on debt securities, net 202 (111) Gain (loss) on equity securities, net 9,758 36,915 Income (loss) and impairment from equity method investments, net (22) 60 Other 384 (142) Other income (expense), net $ 11,183 $ 37,716 OI&E, net increased $26.5 billion from the three months ended March 31, 2025 to the three months ended March 31, 2026, primarily due to increases in net unrealized gains on equity securities resulting from fair value adjustments on non-marketable equity securities.”
“These investments are accounted for under the measurement alternative method ("the measurement alternative") and are measured at cost, less impairment, subject to upward and downward adjustments resulting from observable price changes for identical or similar investments of the same issuer.”
“Sales and Marketing The following table presents sales and marketing expenses (in millions, except percentages): Three Months Ended March 31, 2025 2026 Sales and marketing expenses $ 6,172 $ 7,606 Sales and marketing expenses as a percentage of revenues 7 % 7 % Sales and marketing expenses increased $1.4 billion from the three months ended March 31, 2025 to the three months ended March 31, 2026, primarily driven by increases in advertising and promotional activities of $600 million, employee compensation expenses of $404 million, and office space impairment charges of $300 million.”